<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02086214</url>
  </required_header>
  <id_info>
    <org_study_id>2011_01</org_study_id>
    <secondary_id>N°19/16, Axe 1.11,</secondary_id>
    <secondary_id>2011-A01129-32</secondary_id>
    <nct_id>NCT02086214</nct_id>
  </id_info>
  <brief_title>Pressure Therapy in the Treatment of Upper Arm of Cerebral Palsy Children</brief_title>
  <acronym>PROPENSIX</acronym>
  <official_title>Pressure Therapy in the Treatment of Upper Arm of Cerebral Palsy Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Marc Sautelet Centre (Villeneuve d'Ascq, France)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Lille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the efficacy of a 6 months upper arm proprioceptive
      pressure therapy on Assisting Hand Assessment (&quot;AHA&quot;) performance in Cerebral Palsy (CP). To
      perform this study, 80 CP patients aged of 5 to 10 years old will be included in a
      multicentric, double blind, prospective parallel-group randomized study. Treatment will be a
      pressure therapy using a LYCRA® compressive sleeve initially used in burn therapy. Primary
      outcome is to increase of 60% of AHA performance. The secondary outcome are to increase
      Quality of Upper Extremity Skill Test (QUEST), quality of life and improve Somatosensory
      Evoked Potentials (SEP).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to assess the efficacy of a 6 months upper arm proprioceptive
      pressure therapy on Assisting Hand Assessment (&quot;AHA&quot;) performance in Cerebral Palsy (CP). To
      perform this study, 80 CP patients aged of 5 to 10 years old will be included in a
      multicentric, double blind, prospective parallel-group randomized study. Treatment will be a
      pressure therapy using a LYCRA® compressive sleeve initially used in burn therapy. Primary
      outcome is to increase of 60% of AHA performance. The secondary outcome are to increase
      Quality of Upper Extremity Skill Test (QUEST), quality of life and improve Somatosensory
      Evoked Potentials (SEP)
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 21, 2012</start_date>
  <completion_date type="Anticipated">July 2020</completion_date>
  <primary_completion_date type="Anticipated">July 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assisting Hand Assessment performance</measure>
    <time_frame>6 months</time_frame>
    <description>Assisting Hand Assessment performance is a functional test to assess hand function for children with unilateral upper limb disabilities.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Upper Extremity skill Test (QUEST)</measure>
    <time_frame>6 months</time_frame>
    <description>Upper Extremity skill Test is a functional test to assess upper limb mobility for children with unilateral upper limb disabilities.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Somatosensory Evoked Potentials (SEP)</measure>
    <time_frame>6 months</time_frame>
    <description>Somatosensory Evoked Potentials (SEP) is a functional test to assess sensory nerve conduction</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Cerebral Palsy</condition>
  <arm_group>
    <arm_group_label>Proprioceptive pressure therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Proprioceptive pressure therapy using a a LYCRA® compressive sleeve initially used in burn therapy : 15 to 25 mmHg.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>LYCRA® non-compressive sleeve initially used in burn therapy : &lt; 5 mmHg.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Proprioceptive pressure therapy</intervention_name>
    <description>Proprioceptive pressure therapy using a a LYCRA® compressive sleeve initially used in burn therapy : 15 to 25 mmHg.</description>
    <arm_group_label>Proprioceptive pressure therapy</arm_group_label>
    <other_name>Proprioceptive pressure therapy by Medical Z</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>LYCRA® non-compressive sleeve initially used in burn therapy : &lt; 5 mmHg.</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children with upper limb with pre/peri birth etiologic CP.

          -  Children aged 5 to 10 years

        Exclusion Criteria:

          -  Children with language dysfunction

          -  LYCRA® allergia

          -  Botulic Toxin injection on upper limb 4 month before inclusion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>10 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laurent GOTTRAND, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Marc Sautelet, Villeneuve d'Ascq, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laurent R BEGHIN, PhD</last_name>
    <phone>+33 3 20 44 68 91</phone>
    <email>laurent.beghin@chru-lille.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Laurence GOTTRAND, MD</last_name>
    <phone>+ 33 3 28 80 07 70</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU</name>
      <address>
        <city>Amiens</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Séverine FRITOT, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service d'Education et de Soins Spécialisés à domicile_APF de Creil</name>
      <address>
        <city>Creil</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Yasser MOHAMMAD, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU</name>
      <address>
        <city>Reims</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Mathilde TOUSSAINT, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre de Soins de Suite et de Réadaptation Pédiatrique Spécialisé_Centre Paul Dottin</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Catherine DONSKOFF, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Marc Sautelet</name>
      <address>
        <city>Villeneuve d'Ascq</city>
        <zip>59653</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurence GOTTRAND, MD</last_name>
      <phone>+33 3 28 80 07 70</phone>
    </contact>
    <investigator>
      <last_name>Laurent GOTTRAND, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 17, 2014</study_first_submitted>
  <study_first_submitted_qc>March 11, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 13, 2014</study_first_posted>
  <last_update_submitted>May 15, 2018</last_update_submitted>
  <last_update_submitted_qc>May 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Upper limb</keyword>
  <keyword>Proprioceptive pressure therapy</keyword>
  <keyword>Children</keyword>
  <keyword>Assisting Hand Assessment performance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Paralysis</mesh_term>
    <mesh_term>Cerebral Palsy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

